Physiology and therapeutic potential of the thymic peptide thymulin

Current Pharmaceutical Design

Volumn 20, Issue 29, 2014, Pages 4690-4696

  Reggiani, Paula C ^a,b   Schwerdt, José I ^a,b   Cónsole, Gloria M ^b   Roggero, Eduardo A ^c   Dardenne, Mireille ^d   Goya, Rodolfo G ^a,b  

^a INSTITUTO DE INVESTIGACIONES BIOQUÍMICAS DE LA PLATA INIBIOLP   (Argentina)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^c UNIVERSIDAD ABIERTA INTERAMERICANA   (Argentina)

^d CNRS   (France)

Author keywords

Anti inflammatory; Gene therapy; Neuroendocrine system; Nude mice; Regulatable promoters; Synthetic gene; Thymulin

Indexed keywords

ADENOVIRUS VECTOR; SYNTHETIC DNA; THYMULIN;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOTECHNOLOGICAL PROCEDURES; DRUG ACTIVITY; GENE CONSTRUCT; GENE CONTROL; GENE THERAPY; HUMAN; HYPOPHYSIOTROPIC ACTIVITY; IMMUNE SYSTEM; MOLECULAR BIOLOGY; NEUROENDOCRINE SYSTEM; NEWBORN CARE; NONHUMAN; NUDE MOUSE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; THYMUS; THYMUS DISEASE; NEUROSECRETION;

HUMANS; IMMUNE SYSTEM; NEUROSECRETORY SYSTEMS; THYMIC FACTOR, CIRCULATING; THYMUS GLAND;

EID: 84906262654     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140130211157     Document Type: Article

References (84)

1. Goya RG. The immune-neuroendocrine homeostatic network and ageing. Gerontology 1991; 37: 208-213.
2. Solomon JB. Ontogeny of defined immunity in mammals. In: Neuberger A, ELTatum, Eds. Foetal and Neonatal Immunology. Frontiers of Biology. New York: Am Elsevier Publishing Co 1971; vol 20, 234-306.
3. Jost, A. The extent of foetal and endocrine autonomy. In: Wolstenholme GEW, O'Connor M Eds. Foetal Autonomy. Ciba Foundation Symposium. London, Churchill 1969; pp: 79-94.
4. Rebar RW, Morandini IC, Erickson GF, Petze JE. The hormonal basis of reproductive defects in athymic mice. Endocrinology 1981; 108: 120-6.
5. Besedovsky HO, Sorkin E. Thymus involvement in female sexual maturation. Nature 1974; 249: 356-8.
6. Lintern-Moore S, Pantelouris EM. Ovarian development in athymic nude mice. I. The size and composition of the follicle population. Mech Age Dev 1975; 4: 385-90.
7. Michael SD, Taguchi O, Nishizuka Y. Effects of neonatal thymectomy on ovarian development and plasma LH, FSH, GH and PRL in the mouse. Biol Reprod 1980; 22: 343-50.
8. Nishizuka Y, Sakakura T. Ovarian dysgenesis induced by neonatal thymectomy in the mouse. Endocrinology 1971; 89: 889-93.
9. Pierpaoli W, Besedovsky HO. Role of the thymus in programming of neuroendocrine functions. Clin Exp Immunol 1975; 20(2): 323-8.
10. Lintern-Moore S, Pantelouris EM. Ovarian development in athymic nude mice. III. The effect of PMSG and oestradiol upon the size and composition of the ovarian follicle population. Mech Age Dev 1976; 5(1): 33-8.
11. Goya RG, Cónsole GM, Sosa YE, Gómez-Dumm CLA, Dardenne M. Altered functional responses with preserved morphology of go- nadotrophic cells in congenitally athymic mice. Brain Behav Im- mun 2001; 15: 85-92.
12. Goya RG, Sosa YE, Cónsole GM, Dardenne M. Altered thyrotropic and somatotropic responses to environmental challenges in con-genitally athymic mice. Brain Behav Immun 1995; 9: 79-86.
13. Goya RG, Sosa YE, Cónsole GM, Dardenne M. Altered regulation of serum prolactin in nude mice. Med Sci Res 1996; 24: 279-80.
14. Daneva T, Spinedi E, Hadid R, Gaillard RC. Impaired hypo-thalamo-pituitary-adrenal axis function in swiss nude athymic mice. Neuroendocrinology 1995; 62: 79-86.
15. Savino W, Dardenne M 2000. Neuroendocrine control of thymus physiology. Endocrine Rev 2000; 21: 412-43.
16. Bach J.F. Thymulin (FTS-Zn). Clin Immunol Allergy 1983; 3: 133-56.
17. Dardenne M, Papiernik M, Bach JF, Stutman O. Studies on thymus products. III. Epithelial origin of the serum thymic factor. Immunology 1974; 27: 299-304.
18. Gastinel LN, Dardenne M, Pléau JM, Bach JF. Studies on the zinc-binding site to the serum thymic factor. Biochim Biophys Acta 1984; 797: 147-55.
19. Dardenne M, Nabarra B, Lefrancier P. Contribution of zinc and other metals to the biological activity of serum thymic factor (FTS). Proc Natl Acad Sci USA 1982; 79: 5370-3.
20. Cung MT, Marraud M, Lefrancier P. NMR study of a lymphocyte differentiating thymic factor. J Biol Chem 1988; 263: 5574-80.
21. Savino W, Dardenne M, Bach JF. Thymic hormones containing cells. III. Evidence for a feed-back regulation of the secretion of the serum thymic factor (FTS) by thymic epithelial cells. Clin Exp Immunol 1983; 52: 7-12.
22. Cohen S, Berrih S, Dardenne M, Bach JF. Feed-back regulation of the secretion of a thymic hormone (thymulin) by human thymic epithelial cells in culture. Thymus 1986; 8: 109-19.
23. Timsit J, Savino W, Safieh B, Chanson P, Gagnerault MC, Bach JF, Dardenne M. GH and IGF-I stimulate hormonal function and proliferation of thymic epithelial cells. J Clin Endocrinol Metab 1992; 75: 183-8.
24. Ban E, Gagnerault MC, Jammes H, Postel-Vinay MC, Haour F, Dardenne M. Specific binding sites for growth hormone in cultured mouse thymic epithelial cells. Life Sci 1991; 48: 2141-8.
25. Goff BL, Roth JA, Arp LH, Incefy GS. Growth hormone treatment stimulates thymulin production in aged dogs. Clin Exp Immunol 1987; 68: 580-7.
26. Goya RG, Gagnerault MC, De Moraes MC, Savino W, Dardenne M. In vivo effects of growth hormone on thymus function in aging mice. Brain Behav Immun 1992; 6: 341-54.
27. Goya RG, Gagnerault MC, Sosa YE, Bevilacqua JA, Dardenne M. Effects of growth hormone and thyroxine on thymulin secretion in aging rats. Neuroendocrinology 1993; 58: 338-43.
28. Mocchegiani E, Paolucci P, Balsamo A, Cacciari E, Fabris N. Influence of growth hormone on thymic endocrine activity in humans. Horm Res 1990; 33: 248-55.
29. Dardenne M, Kelly PA, Bach JF, Savino W. Identification and functional activity of prolactin receptors in thymic epithelial cells. Proc Natl Acad Sci USA 1991; 88: 9700-4.
30. Dardenne M, Savino W, Gagnerault MC, Itoh T, Bach JF. Neu-roendocrine control of thymic hormonal production. I. Prolactin stimulates in vivo and in vitro the production of thymulin by human and murine thymic epithelial cells. Endocrinology 1989; 125: 3-12.
31. Fabris N, Mocchegiani E. Endocrine control of thymic serum factor production in young-adult and old mice. Cell Immunol 1985; 91: 325-35.
32. Savino W, Wolf B, Aratan-Spire S, Dardenne M. Thymic hormone containing cells. IV. Fluctuations in the thyroid hormone levels in vivo can modulate the secretion of thymulin by the epithelial cells of young mouse thymus. Clin Exp Immunol 1984; 55: 629-35.
33. Fabris N, Mocchegiani E, Mariotti S, Pacini F, Pinchera A. Thyroid function modulates thymic endocrine activity. J Clin Endocrinol Metab 1986; 62: 474-8.
34. Villa-Verde DM, de Mello-Coelho V, Farias-de-Oliveira DA, Dardenne M, Savino W. Pleiotropic influence of triiodothyronine on thymus physiology. Endocrinology 1993; 133: 867-75.
35. Mocchegiani E, Amadio L, Fabris N. Neuroendocrine-thymus interactions. I. In vitro modulation of thymic factor secretion by thyroid hormones. J Endocrinol Invest 1990; 13: 139-47.
36. Dardenne M, Savino W, Duval D, Kaiserlian D, Hassid J, Bach JF. Thymic hormone-containing cells. VII. Adrenals and gonads control the in vivo secretion of thymulin and its plasmatic inhibitor. J Immunol 1986; 136: 1303-8.
37. Savino W, Bartoccioni E, Homo-Delarche F, Gagnerault MC, Itoh T, Dardenne M. Thymic hormone containing cells. IX. Steroids in vitro modulate thymulin secretion by human and murine thymic epithelial cells. J Steroid Biochem 1988; 30: 479-4.
38. Folch H, Eller G, Mena M, Esquivel P. Neuroendocrine regulation of thymus hormones: hypothalamic dependence of "facteur thymique serique" level. Cell Immunol 1986; 102: 211-6.
39. Goya RG, Gagnerault MC, Sosa YE, Dardenne M. Reduced ability of hypothalamic and pituitary extracts from old mice to stimulate thymulin secretion in vitro. Mech Age Dev 1995; 83: 143-54.
40. Zaidi SA, Kendall MD, Gillham B, Jones MT. The release of LH from pituitaries perifused with thymic extracts. Thymus 1988; 12: 253-64.
41. Hadley AJ, Rantle CM, Buckingham JC. Thymulin stimulates corticotrophin release and cyclic nucleotide formation in the rat anterior pituitary gland. Neuroimmunomodulation 1997; 4: 62-9.
42. Hinojosa L, García L, Domínguez R, et al. Effects of thymulin and GnRH on the release of gonadotropins by in vitro pituitary cells obtained from rats in each day of estrous cycle. Life Sci 2004; 76: 795-804.
43. Brown OA, Sosa YE, Bolognani F, Goya RG. Thymulin stimulates prolactin and thyrotropin release in an age-related manner. Mech Age Dev 1998; 104: 249-62.
44. Brown OA, Sosa YE, Dardenne M, Pléau J, Goya RG. Growth hormone-releasing activity of thymulin on pituitary somatotropes is age dependent. Neuroendocrinology 1999; 69: 20-7
45. Brown OA, Sosa YE, Dardenne M, Pléau JM, Goya RG. Studies on the gonadotropin-releasing activity of thymulin: changes with age. J Gerontol A Biol Sci Med Sci 2000; 55: B170-6.
46. Hinojosa L, Chavira R, Dominguez R, Rosas P. Effects of thymulin on spontaneous puberty and gonadotrophin-induced ovulation in prepubertal normal and hypothymic mice. J Endocrinol 1999; 163: 255-60.
47. García L, Hinojosa L, Domínguez R, Chavira R, Rosas P. Effects of infantile thymectomy on ovarian functions and gonadotrophin-induced ovulation in prepubertal mice: role of thymulin. J Endocri-nol 2000; 166: 381-7.
48. García L, Hinojosa L, Domínguez R, Chavira R, Rosas P. Effects of injecting thymulin into the anterior or medial hypothalamus or the pituitary on induced ovulation in prepubertal mice. Neuroim-munomodulation 2005; 12: 314-20.
49. Wise T. In vitro and in vivo effects of thymulin on rat testicular steroid synthesis. J Steroid Biochem Mol Biol 1998; 66: 129-35.
50. Camihort G, Luna G, Vesenbeckh S, et al. Morphometric assessment of the impact of serum thymulin immunoneutralization on pituitary cell populations in peripubertal mice. Cells Tissues Organs 2006; 184: 23-30.
51. Martines EV, Reggiani PC, Schwerdt JI, Goya RG, Cónsole GM. Thymulin gene therapy prevents the histomorphometric changes induced by thymulin deficiency in the thyrotrope population of mice. Cells Tissues Organs 2011; 194: 67-75.
52. Goya RG, Reggiani PC, Vesenbeckh SM, et al. Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice. Am J Physiol Endocrinol Metab 2007; 293: E182-7.
53. Safieh-Garabedian B, Kanaan SA, Jalakhian RH, Poole S, Jabbur SJ, Saadé NE. Hyperalgesia induced by low doses of thymulin injections: possible involvement of prostaglandin E2. J Neuroimmu-nol 1997; 73: 162-8.
54. Safieh-Garabedian B, Dardenne M, Kanaan SA, Atweh SF, Jabbur SJ, Saadé NE. The role of cytokines and prostaglandin-E2 in thy-mulin induced hyperalgesia. Neuropharmacology 2000; 39: 1653-61.
55. Safieh-Garabedian B, Jalakhian RH, Saade NE, Haddad JJ, Jabbur SJ, Kanaan SA. Thymulin reduces hyperalgesia induced by peripheral endotoxin injection in rats and mice. Brain Res 1996; 717: 179-83.
56. Dardenne M, Saade N, Safieh-Garabedian B. Role of thymulin or its analogue as a new analgesic molecule. Ann N Y Acad Sci 2006; 1088: 153-63.
57. Safieh-Garabedian B, Kendall MD, Khamashta MA, Hughes GRV. Thymulin and its role in immunomodulation. J Autoimmunity 1992; 5: 547-55.
58. Safieh-Garabedian B, Ochoa-Chaar CI, Poole S, et al. Thymulin reverses inflammatory hyperalgesia and modulates the increased concentrationn of proinflammatory cytokines induced by ICV en-dotoxin injection. Neuroscience 2003; 121: 865-73.
59. Safieh-Garabedian B., Dardenne M, Pleau JM, Saadé NE. Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the rat. Br J Pharmacol 2002; 136: 947-55.
60. Safieh-Garabedian B, Jabbur SJ, Dardenne M, Saadé NE. Thy-mulin related peptide attenuates inflammation in the brain induced by intracerebroventricular endotoxin injection. Neuropharmacology 2011; 60: 496-504.
61. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleu-kin-10 and the interleukin-10 receptor. Ann Rev Immunol 2001; 19: 683-765.
62. Saadé NE, Nasr IW, Massaad CA, Safieh-Garabedian B, Jabbut SJ, Kanaan SA. Modulation of ultraviolet-induced hyperalgesia and cytokine upregulation by interleukins 10 and 13. Br J Pharmacol 2000; 131: 1317-24.
63. Safieh-Garabedian B, Mayasi Y, Saadé NE. Targerting neuroin-flammation for therapeutic intervention in neurodegenerative pathologies: a role for the peptide analogue of thymulin (PAT). Expert Opin Ther Targets 2012; 16(11): 1065-73.
64. Yamanouchi T, Moromizato H, Kojima S, et al. Prevention of diabetes by thymic hormone in alloxan-treated rats. Eur J Pharmacol 1994; 257: 39-46.
65. Onodera T, Awaya A. Anti-thyroglobulin antibodies induced with recombinant reovirus infection in BALB/c mice. Immunology 1990; 71: 581-5.
66. Mizutani M, El-Fotoh M, Mori M, et al. In vivo administration of serum thymic factor (FTS) prevents EMC-D virus-induced diabetes and myocarditis in BALB/cAJcl mice. Arch Virol 1996; 141: 73-83.
67. Kohda Y, Matsunaga Y, Yonogi K, Kawai Y, Awaya A, Gemba M. Protective effect of serum thymic factor, FTS, on cephaloridine-induced nephrotoxicity in rats. Biol Pharm Bull 2005; 28: 2087-91.
68. Kohda Y, Kawai Y, Iwamoto N, et al. Serum thymic factor, FTS, attenuates cisplating nephrotoxicity by suppressing cisplatin-induced ERK activation. Biochem Pharmacol 2005; 70: 408-16.
69. Sun X, Yamada H, Yoshihara K, Awaya A, Yoshikai Y. In vivo treatment with a nonapeptide thymic hormone, facteur thymique serique (FTS), ameliorates chronic colitis induced by dextran sulphate sodium in mice. Int Immunopharmacol 2007; 7: 928-36.
70. Henriques-Coelho T, Oliveira SM, Moura RS, et al. Thymulin inhibits monocrotaline-induced pulmonary hypertension modulating interleukin-6 expression and suppressing p38 pathway. Endocrinology 2008; 149: 4367-73.
71. Santos M, Henriques-Coelho T, Leite-Moreira A. Immunomodula-tory role of thymulin in lung diseases. Expert Opin Ther Targets 2010; 14: 131-41.
72. Lunin SM, Khrenov MO, Novoselova TV, Parfenyuk SB, No-voselova EG. Thymulin, a thymic peptide, prevents the overproduction of pro-inflammatory cytokines and heat shock protein Hsp70 in inflammation-bearing mice. Immunol Invest 2008; 37: 858-70.
73. Lunin SM, Glushkova OV, Khrenov MO, et al. Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis. Immunobiology 2012; available from http://dx.dsi.org/10.1016/j.imbio.2012.05.023.
74. Novoselova EG, Lunin SM, Khrenov MO. Involvement of NF-kB transcription factor in the antiinflammatory activity of thymic pep-tides. Dokl Biol Sci 2009; 428: 484-6.
75. Goya RG, Cónsole GM, Hereñú CB, Brown OA, Rimoldi OJ. Thymus and aging: potential of gene therapy for restoration of endocrine thymic function in thymus-deficient animal models. Gerontology 2002; 48: 325-8.
76. Calenda A, Cordonnier A, Lederer F, Le DKH, Pleau JM. Production of biologically active thymulin in Escherichia coli through expression of a chemically synthesized gene. Biotechnol Lett 1988; 10: 155-60.
77. Reggiani PC, Hereñú CB, Rimoldi OJ, et al. Gene therapy for long-term restoration of circulating thymulin in thymectomized mice and rats. Gene Ther 2006; 13: 1214-21.
78. Morel GR, Brown OA, Reggiani PC, et al. Peripheral and mesen-cephalic transfer of a synthetic gene for the thymic peptide thy-mulin. Brain Res Bull 2006; 69: 647-51.
79. Reggiani PC, Barbeito CG, Zuccolilli GO, et al. Neonatal thymulin gene therapy prevents ovarian dysgenesis and attenuates reproductive derangements in nude female mice. Endocrinology 2012; 153: 3922-8.
80. Reggiani PC, Martines E, Ferese C, Goya R, Console GM. Morphological restoration of gonadotrope population by thymulin gene therapy in nude mice. Histol Histopathol 2009; 24: 729-35.
81. Martínes EV, Reggiani PC, Schwerdt JI, Goya RG, Cónsole GM. Morphological Effects on the Corticotrope Population by Thymulin Gene Therapy in Nude Mice. Histol Histopathol 2011; 26: 471-9.
82. Reggiani PC, Martines EV, Camihort GA, Poch B, Goya RG, Cón-sole GM. Role of thymulin on the somatotropic axis in vivo. Life Sci 2012; 91: 166-71.
83. Bach JF, Dardenne M, Goldstein AL. Clinical Aspects of thymulin (FTS). In: Goldstein AL Ed. Thymic Hormones and Lymphokines. Basic Chemistry and Clinical Applications. New York: Plenum Press 1984; pp: 593-600.
84. Sztein MB, Goldstein AL. Thymic hormones-a clinical update. Springer Semin Immunopathol 1986; 9: 1-18.